advisorsecurities master

CAMPCAMP4 Therapeutics Corporation Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
13081
Ticker
CAMP
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2024-10-11
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
CAMP

Detail

Enriched 2026-08-14 20:47

Market cap
$284,128,866.12
Shares outstanding (class)
51,925,800
Shares outstanding (weighted)
62,721,604
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
48
Location
CAMBRIDGE, MA
Description

Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data